Minnesota acute graft-versus-host disease risk score predicts survival at onset of graft-versus-host disease after post-transplant cyclophosphamide prophylaxis.

Authors	Federica Ardizzoia, Francesca Lorentino, Alessandro Bruno, Sarah Marktel, Fabio Giglio, Daniela Clerici, Francesca Farina, Sara Mastaglio, Simona Piemontese, Andrea A Assanelli, Matteo G Carrabba, Massimo Bernardi, Consuelo Corti, Jacopo Peccatori, Fabio Ciceri, Raffaella Greco, Maria Teresa Lupo-Stanghellini
Journal	Haematologica (Haematologica) Vol. 107 Issue 11 Pg. 2748-2751 (11 01 2022) ISSN: 1592-8721 [Electronic] Italy
PMID	35899390 (Publication Type: Journal Article)
Chemical References	Cyclophosphamide
Topics	Humans Graft vs Host Disease (prevention & control) Minnesota Cyclophosphamide (therapeutic use) Hematopoietic Stem Cell Transplantation Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!